Literature DB >> 12670421

Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila.

Yufeng Yang1, Isao Nishimura, Yuzuru Imai, Ryosuke Takahashi, Bingwei Lu.   

Abstract

Parkin, an E3 ubiquitin ligase that degrades proteins with aberrant conformations, is associated with autosomal recessive juvenile Parkinsonism (AR-JP). The molecular basis of selective neuronal death in AR-JP is unknown. Here we show in an organismal system that panneuronal expression of Parkin substrate Pael-R causes age-dependent selective degeneration of Drosophila dopaminergic (DA) neurons. Coexpression of Parkin degrades Pael-R and suppresses its toxicity, whereas interfering with endogenous Drosophila Parkin function promotes Pael-R accumulation and augments its toxicity. Furthermore, overexpression of Parkin can mitigate alpha-Synuclein-induced neuritic pathology and suppress its toxicity. Our study implicates Parkin as a central player in the molecular pathway of Parkinson's disease (PD) and suggests that manipulating Parkin expression may provide a novel avenue of PD therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670421     DOI: 10.1016/s0896-6273(03)00143-0

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  110 in total

Review 1.  Regulation of Parkin E3 ubiquitin ligase activity.

Authors:  Helen Walden; R Julio Martinez-Torres
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

Review 2.  Parkinson's disease: gene therapies.

Authors:  Philippe G Coune; Bernard L Schneider; Patrick Aebischer
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 3.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

4.  Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.

Authors:  Yufeng Yang; Stephan Gehrke; Md Emdadul Haque; Yuzuru Imai; Jon Kosek; Lichuan Yang; M Flint Beal; Isao Nishimura; Kazumasa Wakamatsu; Shosuke Ito; Ryosuke Takahashi; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

Review 5.  RNA interference technologies for understanding and treating neurodegenerative diseases.

Authors:  Bingwei Lu
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

6.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

Authors:  Yufeng Yang; Stephan Gehrke; Yuzuru Imai; Zhinong Huang; Yingshi Ouyang; Ji-Wu Wang; Lichuan Yang; M Flint Beal; Hannes Vogel; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

7.  Antioxidants put Parkinson flies back in the PINK.

Authors:  Ethan Bier
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

8.  Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

Authors:  R Lee Mosley; Eric J Benner; Irena Kadiu; Mark Thomas; Michael D Boska; Khader Hasan; Chad Laurie; Howard E Gendelman
Journal:  Clin Neurosci Res       Date:  2006-12-06

Review 9.  Programmed cell death and new discoveries in the genetics of parkinsonism.

Authors:  Robert E Burke
Journal:  J Neurochem       Date:  2007-12-10       Impact factor: 5.372

10.  Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.

Authors:  Christophe Lo Bianco; Bernard L Schneider; Matthias Bauer; Ali Sajadi; Alexis Brice; Takeshi Iwatsubo; Patrick Aebischer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.